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SUMMARY – Lately there has been an increased consumption of herbal preparations, distrib-
uted as nutritional supplements, often claimed to be ‘natural’ and harmless. However, as their use is not 
subjected to strict pre-marketing testing and regulations, their ingredients are not clearly defined and 
there is no quality control or proof of their effectiveness and safety. A growing body of references ac-
centuate their harmful effects, in particular hepatotoxicity, which varies from minimal hepatogram 
changes to fulminant hepatitis requiring liver transplantation. This case report describes liver damage 
that was highly suspected to originate from Herbalife® products consumption. We excluded alcohol, 
viral, metabolic, autoimmune and neoplastic causes of liver lesions, as well as vascular liver disease, but 
we noticed a connection between the use of Herbalife® products and liver damage. The exact mecha-
nism of liver damage in our patient was not determined. After removing the Herbalife® products, 
liver damage resolved and there was no need to perform liver biopsy. Taking into consideration the 
growing consumption of herbal products and their potential harmfulness, we consider that more strict 
regulations of their production process and sale are necessary, including exact identification of active 
substances with a list of ingredients, toxicologic testing and obligatory side effect report.
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Introduction
Lately there has been an increase in the use of 
herbal preparations, which are important components 
of supplemental and alternative products1. Their popu-
larity is based on their wide availability and the belief 
that they are ‘natural’ and therefore harmless2. In many 
western countries, herbal products are distributed as 
nutritional supplements. Their use is not subjected to 
strict pre-marketing testing and regulations, therefore, 
their ingredients are not defined, there is no quality 
control or proof of their effectiveness and safety3. 
Many references accentuate harmful effects of herbal 
products. Their most frequent harmful side effect is 
hepatotoxicity4. Herbalife® products are connected to 
various grades of liver damage, from minimal hepato-
gram changes to fulminant hepatitis that requires liver 
transplantation5-7. This case report describes liver dam-
age that was likely associated with the use of Herba-
life® products.
Case Report
A 54-year-old female patient was admitted to the 
Department of Gastroenterology and Hepatology for 
icterus, abdominal pain, pale stool, tiredness and gen-
eral weakness, which occurred several days prior to 
hospital admission. The patient did not have any severe 
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Fig. 1. Ultrasound showing a diffuse liver lesion.
Source: Ultrasound Unit, Department of Gastroenterology and 
Hepatology, Sveti Duh University Hospital, Zagreb, Croatia.
illnesses or any similar problems before. She denied 
alcohol or drug addiction, taking any medicine as acute 
or chronic therapy, receiving blood transfusions and/or 
any blood products. Epidemiology and family history 
were negative. At admission, she was hemodynami-
cally stable and not febrile. Icterus was noticed during 
physical examination, however, there was no chronic 
liver disease stigmata. Initial laboratory tests showed 
significantly elevated markers of hepatocellular dam-
age (Table 1). Coagulation parameters and proteino-
gram were normal. Complete blood count, inflamma-
tion parameters, glucose, electrolytes, kidney function 
parameters, thyroid hormones and thyroid-stimulating 
hormone were also normal (Table 2). Serologic tests 
excluded hepatitis B and C infection, as well as cyto-
megalovirus and Epstein-Barr virus infection or reac-
tivation. Positive anti-hepatitis A virus (HAV) anti-
bodies pointed to HAV. The levels of serum copper, 
ferritin and transferrin saturation were normal. Immu-
nologic examination (antinuclear antibodies [ANA], 
antimitochondrial antibodies [AMHA], antibodies 
against smooth muscle cells [AGLM], antibodies 
against liver or kidneys [LKM]) excluded autoimmune 
etiology of liver damage. Upper abdomen ultrasound 
revealed normal size but diffuse hyperechoic liver. 
There were no signs of lithiasis or biliary obstruction 
(Fig. 1). Gastroscopy confirmed Helicobacter (H.) py-
lori positive chronic gastritis, but no signs of portal 
hypertension. Considering elevated hepatogram val-
ues, eradication therapy of H. pylori infection was con-
ducted in later therapeutic period.
Subsequently, we found out that the patient had 
been using the following Herbalife® products: Gua-
rana comprese, RoseOx, Herbalifeline, Tang Kuei Plus 
and Formula 4 at recommended dosage (10 tablets per 
day in total) (Table 3), for approximately half a year 
before admission. During her stay at the Department 
of Gastroenterology and Hepatology, these products 
were excluded from therapy; soon after, the clinical 
picture regressed and the initially high hepatogram 
values decreased (Table 1, Figs. 2 and 3).
According to the World Health Organization cri-
teria (WHO-UMC Criteria) for the cause and effect 
of liver failure and Herbalife® products, the patient’s 
toxic hepatitis was probably the result of taking the 
aforementioned products8.
Discussion and Conclusion
Liver damage frequently occurs as a result of using 
medicines and their byproducts, since it is the most 
important organ for metabolizing medicines1. Hepa-
totoxicity occurs in 10% of cases and is the most com-
mon cause of side effect reporting, as well as putting 
medical products off the market. Harmful effects of 
conventional medical products are well known, how-
ever, side effects of herbal products are becoming more 
frequent as they are being more widespread. It is 
known that up to 67% of Americans use herbal prod-
ucts9, and their use is steadily increasing1.
Hepatotoxicity due to herbal products is more fre-
quently caused by an idiosyncratic reaction than by 
toxic damage. There is a wide span of liver damage 
manifestations caused by harmful effects of medicinal 
products, starting from highly elevated liver enzymes 
to steatosis, acute and chronic hepatitis, hepatic fibro-
sis and cirrhosis, partial or diffuse necrosis, cholestasis, 
veno-occlusive disease, carcinogenesis, up to acute liver 
failure that requires transplantation10. In addition, the 
same medicinal product produced in different coun-
tries can cause different types of liver damage. The risk 
factors that influence the tendency towards developing 
liver lesions caused by medication are older age, female 
gender, parallel use of other drugs that induce cyto-
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chrome P450 and genetic polymorphism of pathways 
included in the drug metabolism11,12. One of the most 
important predisposing factors is a pre-existing liver 
disease.
Some of the herbal preparations connected to hep-
atotoxicity are Kava Kava (Piper methysticum rhizoma), 
Jin Bu Huan (Lypocodium serratum), Ma Huang (Ephe-
dra spp.), Germander (Teucrium chamaedrys), Chapar-
ral (Larrea tridentata), and pyrrolizidine alkaloids (He-
liotropium, Senecio, Symphyíum and Crotalaria spp.). In 
the last few years, there have been more than 50 cases 
of liver damage connected with Herbalife® use, some 
of them even life threatening.
Herbalife® is one of the world’s leading companies 
that manufacture supplements, with internet sales of 
approximately 1.2 billion dollars per year. It sells prod-
ucts for weight loss, improving general wellbeing, as 
well as personal hygiene products, and it has wide-
spread distributers in 59 countries. Some products are 
registered as dietary supplements, whereas others are 
not registered at all.
Herbalife® products contain herbal extracts en-
riched with vitamins, minerals and oligo-elements. Be-
cause of the lack of the production process standardiza-
tion, which varies among countries, and because of the 
complexity and variability of herbal extracts, their exact 
ingredients are unknown. Besides being contaminated 
by other chemicals such as softeners, preservatives, fla-
vor enhancers and pesticides, we can also find traces of 
heavy metals which were added during the production 
process or are found in unprocessed raw materials13. A 
number of heavy liver failure cases caused by Herbalife® 
products that were contaminated with Bacillus subtilis 
have been described14. Considering everything men-
tioned above and the fact that patients use more than 
one product at the same time, it is difficult to identify 
the exact culprit substance.
Fig. 2. AST and ALT values on admission and follow-up 
measurements.
AST = aspartate aminotransferase; ALT = alanine aminotransferase
Fig. 3. Other hepatogam findings on admission  
and follow-up measurements.
GGT = gamma-glutamyl transferase; ALP = alkaline phosphatase; 
Conj. bilirubin = conjugated bilirubin; Dir. bilirubin = direct bilirubin
Table 1. Hepatogram values on admission and follow-up measurements
Days after admission Month Year
1 3 6 8 9 13 16 20 1 2
AST 1411 1450 1055 688 544 227 143 78 45 17
ALT 2196 2132 1932 1393 1184 587 330 156 58 11
GGT 252 216 213 187 168 131 110 84 55 30
ALP 216 199 188 164 142 121 104 82 68 60
Conj. bil. 123.6 146.2 160.7 107.8 86.2 49.2 39.8 28 22 22
Dir. bil. 69.8 79.6 82.1 50.8 38.8 19.5 13.9 10.1 87.0 8.7
AST = aspartate aminotransferase; ALT = alanine aminotransferase; GGT = gamma-glutamyl transferase; ALP = alkaline phosphatase; 
Conj. bil. = conjugated bilirubin; Dir. bil. = direct bilirubin
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There is a proof of harmful effects of green tea and 
aloe vera, which are the two main ingredients of some 
Herbalife® products. There have been case reports of 
hepatotoxicity (4 in Spain15, 9 in France16) in 2003 
caused by the product Exolise, which contains the eth-
anol extract of green tea, which was taken off the mar-
ket in Spain. Not one Herbalife® product containing 
green tea has the type of extract and its amount speci-
fied. Several authors state that there is a connection 
between liver damage and oral use of products con-
taining aloe vera17-19. Aloe vera is the main ingredient 
of Herbalife® drink Herbal Aloe.
The exact mechanism of liver damage is unknown. 
Most probably, it is immune mediated hepatotoxicity, 
where genetic susceptibility plays an important role4. 
Family connection in two cases of hepatitis in Spain, 
one of which was autoimmune hepatitis, favors this 
statement20. It is possible that autoimmune mecha-
nisms lead to compromised liver microcirculation, the 
same as in veno-occlusive liver disease. It is also known 
that one of the causes for this condition is the use of 
herbal products containing pyrrolizidine alkaloids.
We excluded alcohol, viral, metabolic, autoimmune 
and neoplastic causes of liver lesions, as well as vascular 
liver disease, and we noticed a connection between the 
use of Herbalife® products and liver damage. The exact 
mechanism of our patient’s liver damage was not de-
termined. After removing the Herbalife® products, 
liver damage resolved and there was no need to per-
form liver biopsy.
In two series of hepatotoxicity cases caused by 
Herbalife® described in Switzerland and Israel, the 
histopathologic forms of liver damage were different. 
In the Switzerland cases, there was predominantly 
cholestatic hepatitis with two cases of giant cell hepa-
titis/sinusoid obstruction syndrome5, whereas in Israel 
cases there was predominantly hepatocellular hepati-
tis4. In the case described in Argentina, there was also 
predominantly hepatocellular hepatitis7. Different 
mechanisms of liver damage are caused by ‘geographi-
cal’ variations of Herbalife® product ingredients, and 
the aforementioned fact that the same substance can 
cause various types of liver failure.
Even though Herbalife® products are very widely 
used, the recorded frequency of their side effects is 
low. The real side effects are actually unknown be- 
cause of imprecise data on total consumption of Herb-
alife® products, as well as the fact that liver damage 
Table 2. Laboratory parameters (values other than hepatogram) on follow-up measurements
Days after admission Month Year
1 3 6 8 9 13 16 20 1 2
L 6.5 4.64 5.58
RBC 4.49 4.43 4.72
Hb 136 130 136
Htc 0.41 0.39 0.4
T 238 209 275
CRP 5 5 3.8
Na 138 138 138 139
K 4.1 4.1 4.7 3.7
Urea 2.3 2.1 2.9
Creatinine 88 87 81
BG 5.6 4.7 4.1 5.5
S. amylase 58 52 58
Albumins 40
PT 0.9 0.84 0.78 0.86 0.91 0.97
INR 1.05 1.12 1.05
AFP 12.1 27.6
L = leukocyte count; RBC = red blood cell count; Hb = hemoglobin; Htc = hematocrit; Plt = platelet count; CRP = C-reactive protein; Na 
= sodium; K = potassium; BG = blood glucose; S. amylase = serum amylase; PT = prothrombin time; INR = International Normalized 
Ratio; AFP = alpha fetoprotein
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necessary, including exact identification of active sub-
stances with the list of ingredients, toxicologic testing 
and obligatory side effect report. Until then, the public 
at large, physicians and pharmacists have to be in-
formed about the potential risk of their use.
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Sažetak
OZBILJNA HEPATOTOKSIČNOST UDRUŽENA S PRIPRAVKOM HERBALIFE®  
U PRETHODNO ZDRAVE ŽENE
D. Jurčić, M. Gabrić, R. Troskot Perić, A. M. Liberati Pršo, J. Mirat, A. Včev, I. Alerić i B. Ebling
U novije vrijeme bilježi se porast upotrebe biljnih pripravaka koji su važan sastojak komplementarnih i alternativnih 
pripravaka te su široko dostupni pod krinkom “prirodnosti” i neškodljvosti. No budući da njihova upotreba ne podliježe 
strogim predmarketinškim testiranjima i regulativama, često nemaju jasno i detaljno definiran sastav, osiguranu kontrolu 
kvalitete, kao niti dokaz o učinkovitosti i sigurnosti. Štoviše, sve je više literaturnih podataka koji svjedoče štetnim učincima 
biljnih pripravaka, a kao najčešća posljedica njihove upotrebe navodi se hepatotoksičnost s različitim stupnjevima jetrenog 
oštećenja, od minimalnih promjena hepatograma sve do fulminantnog hepatitisa koji zahtijeva transplantacijsko liječenje. 
Prikazuje se slučaj jetrenog oštećenja visoko povezanog s uporabom određenih proizvoda Herbalife®, nakon što su kao mo-
guć uzrok jetrenog oštećenja isključeni alkohol, virusne bolesti, metabolička, vaskularna, autoimuna i neoplastična zbivanja. 
Točan mehanizam jetrenog oštećenja u prikazane bolesnice nismo otkrili, a budući da su se jetrena funkcija i morfologija u 
potpunosti oporavile nakon ukidanja sumnjivih pripravaka Herbalife® nije bilo potrebe za biopsiju jetre. Imajući u vidu sve 
učestaliju konzumaciju biljnih pripravaka s potencijalno štetnim djelovanjem, smatramo da je neophodno uvođenje kako 
stroge regulacije proizvodnih i prodajnih procesa, tako i točne i detaljne identifikacije aktivnih tvari na popisu sastojaka te 
toksikološka testiranja uz obvezu prijavljivanja nuspojava.
Ključne riječi: Herbalife; Biljni pripravci; Prehrana, dodaci; Zatajenje jetre
